Predict your next investment

Asset/Investment Management
athyrium.com

See what CB Insights has to offer

Investments

18

Portfolio Exits

8

Funds

4

About Athyrium Capital Management

Athyrium Capital Management (Athyrium) is a specialized asset management company formed in 2008 by Jeffrey A. Ferrell to focus on investment opportunities in the global healthcare sector. Athyrium invests across healthcare verticals including biopharma, medical devices and products, and healthcare services. The team partners with management teams to implement creative financing solutions to companies' capital needs. In addition, Athyrium manages similar healthcare assets on behalf of other institutional investors.

Athyrium Capital Management Headquarter Location

126 East 56th Street Floor 4

New York, New York, 10022,

United States

212-402-6925

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Athyrium Capital Management

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Athyrium Capital Management in 1 Expert Collection, including Pharma Startups.

P

Pharma Startups

5,090 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

Latest Athyrium Capital Management News

Athyrium Capital Management Investments

18 Investments

Athyrium Capital Management has made 18 investments. Their latest investment was in BioCryst Pharmaceuticals as part of their PIPE - II on December 12, 2020.

CBI Logo

Athyrium Capital Management Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

12/7/2020

PIPE - II

BioCryst Pharmaceuticals

$325M

Yes

2

3/5/2019

Series A

Secura Bio

$55M

No

3

3/5/2019

Debt

Secura Bio

$50M

Yes

3

7/25/2018

Unattributed

Subscribe to see more

$99M

Subscribe to see more

10

1/4/2018

Series A - II

Subscribe to see more

$99M

Subscribe to see more

10

Date

12/7/2020

3/5/2019

3/5/2019

7/25/2018

1/4/2018

Round

PIPE - II

Series A

Debt

Unattributed

Series A - II

Company

BioCryst Pharmaceuticals

Secura Bio

Secura Bio

Subscribe to see more

Subscribe to see more

Amount

$325M

$55M

$50M

$99M

$99M

New?

Yes

No

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

2

3

3

10

10

Athyrium Capital Management Portfolio Exits

8 Portfolio Exits

Athyrium Capital Management has 8 portfolio exits. Their latest portfolio exit was Clover Health on January 07, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

1/7/2021

Reverse Merger

$991

4

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

00/00/0000

Subscribe to see more

Subscribe to see more

$991

Subscribe to see more

10

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

Date

1/7/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Exit

Reverse Merger

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$991

$991

Acquirer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

4

10

10

10

10

Athyrium Capital Management Acquisitions

1 Acquisition

Athyrium Capital Management acquired 1 company. Their latest acquisition was Interamerican Medical Center Group on February 02, 2017.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

2/2/2017

Acq - Fin

Acq - Fin

1

Date

2/2/2017

Investment Stage

Acq - Fin

Companies

Valuation

Total Funding

Note

Acq - Fin

Sources

1

Athyrium Capital Management Fund History

4 Fund Histories

Athyrium Capital Management has 4 funds, including Athyrium Healthcare Strategic Income & Growth IDF.

Closing Date

Fund

Fund Type

Status

Amount

Sources

1/6/2020

Athyrium Healthcare Strategic Income & Growth IDF

Private Debt (Other)

$26M

1

12/4/2017

Athyrium Opportunities Fund III

Subscribe to see more

$99M

10

7/21/2015

Athyrium Opportunities Fund II

Subscribe to see more

$99M

10

5/20/2013

Athyrium Opportunities Fund

Subscribe to see more

$99M

10

Closing Date

1/6/2020

12/4/2017

7/21/2015

5/20/2013

Fund

Athyrium Healthcare Strategic Income & Growth IDF

Athyrium Opportunities Fund III

Athyrium Opportunities Fund II

Athyrium Opportunities Fund

Fund Type

Private Debt (Other)

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Amount

$26M

$99M

$99M

$99M

Sources

1

10

10

10

Athyrium Capital Management Team

1 Team Member

Athyrium Capital Management has 1 team member, including current Managing Partner, Jeffrey Ferrell.

Name

Work History

Title

Status

Jeffrey Ferrell

Managing Partner

Current

Name

Jeffrey Ferrell

Work History

Title

Managing Partner

Status

Current

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.